International Paper
IP
$37.18
+1.39%
International Paper Co. is a global leader in packaging and container products, manufacturing corrugated packaging that serves industrial, consumer, and manufacturing end markets. With roughly one-third of the North American corrugated packaging market and a substantial European presence following its acquisition of DS Smith, the company is a dominant player in the packaging industry. The current investor narrative revolves around the company's post-acquisition integration and margin recovery, as it navigates a challenging demand environment while seeking to leverage its expanded scale and cost synergies. Recent news of a $360 million mill acquisition underscores management's commitment to strategic growth, even as the stock faces headwinds from cyclical pressures and a broader market rotation.…
IP
International Paper
$37.18
Related headlines
Investment Opinion: Should I buy IP Today?
Rating: Hold. International Paper is a deep-value turnaround play with a low valuation and analyst consensus Buy, but the current unprofitability and negative momentum warrant caution. The average analyst target of ~$56 implies 44% upside, but the stock has declined 23% over the past year, indicating that the market is pricing in significant execution risk.
Supporting Evidence: The stock trades at a trailing PS of 0.84x, well below the industry average of ~1.2x, and a forward PE of 14.52x based on estimated EPS of $3.86. Revenue grew 31.1% YoY to $6.006B, driven by the DS Smith acquisition, but the company remains unprofitable with a net margin of -39.7%. Free cash flow turned positive in Q4 2025 at $255M, but TTM free cash flow is still negative at -$159M. The analyst consensus is Buy, with a high EPS estimate of $4.00 implying a target of $58, offering 50% upside.
Risks & Conditions: The biggest risks are failure to achieve the expected EPS recovery of $3.86, continued margin compression, and integration challenges from recent acquisitions. This Hold would upgrade to Buy if the company reports a profitable quarter with positive free cash flow and the stock holds above $35, or downgrade to Sell if revenue growth decelerates below 10% or losses widen. Overall, IP appears undervalued relative to its historical multiples and forward earnings potential, but the current financial distress makes it a high-risk investment suitable only for patient, contrarian investors.
Sign up to view all
IP 12-Month Price Forecast
International Paper is a high-risk turnaround play with a low valuation that prices in significant distress. The bull case relies on successful integration and margin recovery, while the bear case highlights persistent losses and negative momentum. The base case of gradual improvement is most likely, but the stock's 23% annual decline and high short interest suggest the market is skeptical. The neutral stance reflects the balanced risk/reward: the low valuation provides a floor, but the lack of profitability and negative technical trends cap upside. An upgrade to bullish would require a profitable quarter with positive free cash flow, while a downgrade to bearish would follow a further deterioration in margins or a recession.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on International Paper's 12-month outlook, with a consensus price target around $48.33 and implied upside of +30.0% versus the current price.
Average Target
$48.33
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$30 - $48
Analyst target range
Seven analysts cover International Paper, with a consensus leaning bullish. Recent ratings include multiple Buy ratings from Citigroup, UBS, Truist Securities, and Argus Research, while Wells Fargo and JP Morgan hold Neutral/Equal Weight stances. The average estimated EPS for the next fiscal year is $3.86, with a range of $3.75 to $4.00, and estimated revenue of $27.04 billion. The consensus recommendation is a Buy, with an implied upside based on the average target price (not explicitly provided, but the forward PE of 14.52 on $3.86 EPS implies a target of ~$56, which is 44% above the current price of $38.79). The high EPS estimate of $4.00 suggests a target of $58, while the low estimate of $3.75 implies a target of $54. The wide range of EPS estimates (6.8% spread) indicates moderate uncertainty. Recent analyst actions show a mix of upgrades and downgrades: UBS downgraded from Buy to Neutral in February 2026, while Wells Fargo upgraded from Underweight to Equal Weight in January 2026. The overall sentiment remains positive, but the divergence in ratings suggests that the recovery story is not fully de-risked. The limited number of analysts (7) is typical for a mid-cap stock, and the coverage is sufficient to provide a reasonable consensus view.
Drowning in data?
Find the real signal!
Bulls vs Bears: IP Investment Factors
International Paper presents a classic deep-value turnaround story, trading at a low 0.84x sales and 1.40x book value, with analysts expecting a sharp earnings recovery to $3.86 EPS. The bull case rests on successful integration of DS Smith and NORPAC, margin normalization, and the low valuation providing a safety net. However, the bear case highlights the company's current unprofitability, negative operating margins, and a 23% stock decline over the past year, reflecting skepticism about the recovery timeline. The single most important tension is whether the company can return to sustainable profitability and generate the expected $3.86 EPS, as failure to do so would leave the stock stuck in a value trap. Currently, the bearish evidence is stronger given the deep losses and negative momentum, but the low valuation and analyst targets offer a compelling risk/reward for patient investors.
Bullish
- Low Valuation with Forward PE of 14.5x: The forward PE ratio of 14.52x is well below the market average and implies significant earnings recovery, as analysts expect EPS of $3.86 next year. This low multiple provides a margin of safety if the turnaround materializes.
- Analyst Consensus Buy with 44% Upside: Seven analysts rate IP a Buy, with an average target price of ~$56, implying 44% upside from the current $38.79. The high EPS estimate of $4.00 suggests a target of $58, offering substantial potential return.
- Strategic Acquisitions Expanding Scale: The $360 million NORPAC mill acquisition strengthens West Coast presence and complements the DS Smith deal, which boosted revenue 31.1% YoY to $6.006B. These moves position IP for long-term market share gains.
- Positive Free Cash Flow in Q4 2025: Despite a TTM free cash flow of -$159M, Q4 2025 generated $255M in free cash flow, indicating improving cash generation. This could support debt reduction or reinvestment as integration progresses.
Bearish
- Deeply Unprofitable with -39.7% Net Margin: The most recent quarter reported a net loss of $2.384B and a net margin of -39.7%, driven by impairment charges. Even on an adjusted basis, the company has struggled to achieve consistent profitability.
- Stock Down 23% Over Past Year: IP has declined 23.0% over the last year versus the S&P 500's gain of 19.1%, reflecting persistent selling pressure. The stock trades near the bottom of its 52-week range, indicating weak momentum.
- High Short Ratio of 8.07 Days: The short ratio of 8.07 days suggests significant bearish sentiment and a high level of short interest. This could lead to a short squeeze, but also reflects skepticism about the turnaround story.
- Negative Operating Margin of -42.7%: Operating margin plunged to -42.7% in Q4 2025, indicating severe operational inefficiencies or one-time charges. Even excluding impairments, the core business faces margin pressure from rising costs.
IP Technical Analysis
International Paper is in a sustained downtrend, with the stock price declining 23.0% over the past year compared to the S&P 500's gain of 19.1%. The current price of $38.79 sits at 34.6% of its 52-week range ($29.26 low to $56.13 high), indicating the stock is trading near the lower end of its range. This positioning suggests a potential value opportunity, but also reflects persistent selling pressure and a lack of momentum. The stock's beta of 0.898 indicates it is slightly less volatile than the market, which may provide some downside protection but also limits upside participation in rallies. Over the past three months, the stock has gained 11.5%, while the S&P 500 rose 13.6%, showing a modest recovery but still underperforming. The one-month price change of +14.7% is a sharp reversal from the six-month decline of -3.6%, suggesting a short-term bounce that could be either a trend reversal or a temporary relief rally. The relative strength versus the S&P 500 over one month is +15.9%, indicating the stock is outperforming recently, but the three-month relative strength is -2.1%, highlighting the longer-term weakness. The 52-week low of $29.26 provides key support, while the 52-week high of $56.13 is a major resistance level. A breakout above $56.13 would signal a significant trend reversal, while a breakdown below $29.26 could accelerate selling. The stock's beta of 0.898 suggests it is less volatile than the market, which may appeal to risk-averse investors but also means it may lag during broad market rallies.
Beta
0.90
0.90x market volatility
Max Drawdown
-47.2%
Largest decline past year
52-Week Range
$29-$56
Price range past year
Annual Return
-27.6%
Cumulative gain past year
| Period | IP Return | S&P 500 |
|---|---|---|
| 1m | +9.0% | +2.0% |
| 3m | +1.9% | +10.6% |
| 6m | -14.2% | +8.3% |
| 1y | -27.6% | +20.4% |
| ytd | -7.6% | +10.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
IP Fundamental Analysis
Revenue has grown significantly, with the most recent quarterly revenue of $6.006 billion representing a 31.1% year-over-year increase, driven largely by the DS Smith acquisition. However, the growth trajectory is uneven: revenue in Q4 2025 was $6.006B, down from $6.767B in Q2 2025, indicating potential post-acquisition integration challenges or demand softness. The company's revenue segments show North America Packaging Solutions at $3.702B, EMEA at $1.550B, and Global Cellulose Fibers at $0.643B, highlighting the dominance of the North American business. The company is currently unprofitable, with a net loss of $2.384 billion in the most recent quarter and a trailing twelve-month net income of -$3.06 billion. Gross margin has been volatile, coming in at 31.4% in Q4 2025, down from 31.1% in Q3 2025 but up from 27.8% in Q2 2025. Operating margin was deeply negative at -42.7% in Q4 2025, reflecting significant impairment or restructuring charges. The net margin of -39.7% underscores the severity of the losses, though this may be partly due to non-recurring items. The company's balance sheet shows a debt-to-equity ratio of 0.73, which is manageable but elevated. Free cash flow was positive at $255 million in Q4 2025, but trailing twelve-month free cash flow is -$159 million, indicating cash generation challenges. The current ratio of 1.28 suggests adequate liquidity, but the negative free cash flow raises concerns about the company's ability to fund operations without external financing. Return on equity is deeply negative at -23.7%, reflecting the net loss position.
Quarterly Revenue
$6.0B
2025-12
Revenue YoY Growth
+31.14%
YoY Comparison
Gross Margin
31.35%
Latest Quarter
Free Cash Flow
$-159000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is IP Overvalued?
Since net income is negative, the price-to-sales (PS) ratio is the most appropriate valuation metric. The trailing PS ratio is 0.84, while the forward PS ratio is not directly provided but can be inferred from estimated revenue. The PS ratio of 0.84 is relatively low, suggesting the market is pricing in significant margin compression or further deterioration. The company's EV/Sales ratio of 1.19 also supports a low valuation multiple. Compared to the industry average PS ratio (not provided, but typically for packaging companies around 1.0-1.5x), International Paper trades at a discount, reflecting its current unprofitability and cyclical headwinds. The PB ratio of 1.40 is also below historical levels, indicating the stock is trading near book value. Historically, the stock's trailing PE ratio has ranged from negative values to over 80x in recent quarters. The current negative PE of -5.87 is near the bottom of its historical range, which typically signals deep value but also fundamental distress. The forward PE of 14.52 (based on estimated EPS of $3.86) implies a significant earnings recovery is expected, but the gap between trailing and forward PE highlights the market's expectation of a sharp turnaround. The PEG ratio of 0.01 is extremely low, suggesting the stock is cheap relative to expected earnings growth, but this should be treated with caution given the high uncertainty.
PE
-5.9x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -56x~82x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-220.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: International Paper's most immediate financial risk is its deep unprofitability, with a trailing net loss of $3.06 billion and a net margin of -39.7% in the most recent quarter. The company carries a debt-to-equity ratio of 0.73, which is manageable but elevated, and negative trailing free cash flow of -$159 million raises concerns about liquidity if losses persist. The gross margin of 31.4% is volatile and has declined from 31.1% in the prior quarter, indicating cost pressures that could delay the path to profitability. Additionally, the company's return on equity is deeply negative at -23.7%, reflecting the erosion of shareholder equity from sustained losses.
Market & Competitive Risks: The stock trades at a low valuation (PS 0.84x, PB 1.40x) which already prices in significant distress, but further compression could occur if the recovery disappoints. With a beta of 0.898, IP is slightly less volatile than the market, but its cyclical exposure to industrial and consumer demand makes it sensitive to economic downturns. The packaging industry faces competitive pressures from alternative materials and potential overcapacity, while the DS Smith integration carries execution risk. Recent news of the $360 million NORPAC acquisition adds integration complexity, and any antitrust or regulatory hurdles could delay synergies.
Worst-Case Scenario: In a severe downturn where demand weakens and integration fails to deliver cost savings, IP could see its stock fall to the 52-week low of $29.26, representing a 24.6% decline from the current price of $38.79. If the company continues to report losses and free cash flow turns more negative, the stock could test even lower levels, potentially revisiting the historical max drawdown of -47.23%, which would imply a price near $20.50. In this scenario, an investor could lose up to 47% of their investment from the current price.
FAQ
The primary risk is that the company fails to achieve the expected earnings recovery, leading to continued losses and a potential value trap. Financial risks include a net loss of $2.384B in the most recent quarter, negative TTM free cash flow of -$159M, and a debt-to-equity ratio of 0.73. Market risks include the stock's 23% annual decline and high short interest (8.07 days to cover), indicating bearish sentiment. Company-specific risks include integration challenges from the DS Smith and NORPAC acquisitions, which could delay cost synergies. The worst-case scenario is a drop to the 52-week low of $29.26, a 24.6% decline from current levels.
The 12-month forecast for IP is mixed, with three scenarios: a bull case (25% probability) where successful integration drives the stock to $50-$58, a base case (50% probability) of gradual improvement to $42-$50, and a bear case (25% probability) of continued losses pushing the stock to $29-$35. The base case is most likely, assuming gradual margin recovery and positive free cash flow. The analyst consensus is Buy with an average target of ~$56, implying 44% upside. However, the stock's recent decline and high short interest suggest near-term volatility.
International Paper appears undervalued based on forward earnings and sales multiples. The trailing PS ratio of 0.84x is below the industry average of ~1.2x, and the forward PE of 14.52x is reasonable for a company expected to grow earnings significantly. The PB ratio of 1.40x is near book value, suggesting limited downside. However, the current negative trailing PE of -5.87x reflects the company's losses, so the valuation is only attractive if the earnings recovery materializes. The market is pricing in a turnaround, but the low multiples provide a margin of safety.
International Paper is a high-risk, high-reward investment. The stock trades at a low 0.84x sales and 14.5x forward earnings, with analysts expecting a sharp turnaround to $3.86 EPS. If successful, the stock could rise 44% to the average target of $56. However, the company is currently unprofitable with a net margin of -39.7%, and the stock has declined 23% over the past year. It is a good buy only for patient, contrarian investors who can tolerate near-term volatility and have a 12-24 month horizon. For risk-averse investors, it is better to wait for evidence of sustainable profitability.
International Paper is better suited for long-term investment (12-24 months) due to its turnaround nature and low beta of 0.898, which limits short-term upside. The stock's 23% annual decline and high short interest make it risky for short-term trading, as momentum is negative. Long-term investors can benefit from the low valuation and potential earnings recovery, but must be patient. The company pays a dividend yield of 4.7%, providing some income while waiting for the turnaround. A minimum holding period of 12 months is recommended to allow integration benefits to materialize.
